NIH – Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

January 10, 2019 by

This Funding Opportunity Announcement (FOA), Stimulating Hematology Investigation:  New Endeavors (SHINE) is intended to promote and support innovative, high-quality hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute on Aging (NIA), or the National Heart, Lung, and Blood Institute (NHLBI).  Investigator-initiated research project grant applications are invited in particular areas of basic and early translational hematology research.  The specific areas that will be considered for funding through this FOA  change on an annual basis and will be listed in this FOA and updated as annual Notices that will be hyperlinked to this FOA.

The overall objectives of the SHINE program are to catalyze discoveries in basic molecular and cellular biology that provide new insights into the pathogenesis, prevention, detection, and potential treatment of nonmalignant hematologic diseases; to attract new investigators into basic and translational hematology research; to promote productive interdisciplinary research collaborations; and to reinforce a flexible, proactive role for the NIA, NHLBI, and NIDDK to support timely, high impact, leading-edge research by the hematology research community.

The focus of research supported by the SHINE program will vary.  In general, the knowledge gaps and research opportunities addressed by the SHINE program will include those that are defined and highlighted by workshops and other public meetings.  These workshops are open to the public and interested researchers are invited to attend and participate.

Specific research objectives supported by the “Stimulating Hematology Investigation:  New Endeavors (SHINE)” program in FY2019 are currently:

Applicants are strongly encouraged to contact one of the NIDDK, NIA, or NHLBI Scientific/Research staff to discuss plans for preparing an R01 application.

Deadlines:  standard dates apply


Filed Under: Funding Opportunities